Automation helps pharmacists increase their role in patient care by promoting adherence.
In this age of emerging technology, it more important than ever for community pharmacists to get plugged into clinical data sharing.
The role of lead pharmacist provides a pathway to leadership.
How a pharmacy performs with respect to specific measures can be associated with a DIR fee.
They should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.
A state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.
Alpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
TNF-alpha inhibitors are used to treat a number of inflammatory conditions.
There are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.
Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
Based on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.
Recognizing that culture is a multifaceted concept can lead to more careful and thoughtful use of the term.
Myasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.
Clinicians have long been aware that patients do not uniformly respond to medications.
As more pharmacists graduate from pharmacy schools, landing a job has become increasingly competitive.
Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.
HIV is of interest among many in managed care. This paper focuses on the costs and demographic characteristics associated with new HIV therapy initiators.
Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.